Publication | Open Access

PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures

MedicinePathologyPd-1/pd-l1 Checkpoint InhibitorsImmune Checkpoint InhibitorTumor TargetingAnti-cancer AgentCell BiologyCancer TreatmentOncologyRadiation OncologyOvarian Cancer